Print

Shire Pharmaceuticals (SHPGY)'s Gaucher Medicine Vpriv Gets EU Agency OK  
6/25/2010 7:11:49 AM

LONDON, June 25 (Reuters) - The European Medicines Agency recommended approval of Shire's (SHP.L) Vpriv drug on Friday to treat Gaucher disease, following an accelerated approval process.
//-->